Analysts noted the effects of VX-548 appear comparable to 'g...
Analysts noted the effects of VX-548 appear comparable to 'gold standard' pain medicine pregabalin. Jefferies analysts stated the new data on the pain medicine 'looks at least as good as or better than investor expectations'.
Vertex's Stock Heads for All-time High as Non-opioid Painkiller Shows Promise
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment